News summary

Rejuvenation Roundup October 2026

Source: Lifespan.io • Published: 02 Nov 2026, 19:59

Summarized by Masters of Longevity from Lifespan.io.

FDA officials prioritized aging while multiple preclinical and clinical longevity findings arose.

Rejuvenation Roundup October 2026
Key Takeaways
  • FDA leaders said aging is a priority in regulatory science.
  • Mouse studies showed autophagy activation reduced senescent cells.
  • Human trials reported diet and exercise benefits for aging outcomes.
Read the full article at Lifespan.io ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickCan Exergaming Improve Balance? What Older Adults Should KnowMotion-controlled games may make balance practice easier to repeat. The evidence supports a structured adjunct—not a fall-proofing shortcut.